Analyst stock forecast
Medline Forecast: $44.54 Analyst Target
Direct answer
Medline's average price target is $44.54.
The target implies +28.4% from the recorded current price, and the consensus rating is Buy.
The low target implies -2%, the high target implies +58.5%, and the range spans 60.5% of the current price.
Forecast evidence checked September 27, 2026.
Get free Medline email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $34.70
- Average price target
- $44.54
- High price target
- $55.00
- Low price target
- $34.00
- Low target gap
- -2%
- Target upside
- +28.4%
- High target gap
- +58.5%
- Target range width
- 60.5%
- Consensus rating
- Buy
- Analysts
- 26
- Evidence date
- September 27, 2026
- Valid through
- October 4, 2026
Explore related company data
Read the frequently asked questions.
What is Medline's average price target?
Medline's verified average price target is $44.54. The target range is $34.00 to $55.00.
How far are Medline's low and high targets from the recorded price?
The low target implies -2%, while the high target implies +58.5%.
How many analysts are included in Medline's consensus?
The verified consensus includes 26 analysts.
How is Medline's target upside or downside calculated?
The average target of $44.54 is divided by the recorded price of $34.70, then one is subtracted to produce +28.4%. This does not guarantee a future return.
When was Medline's analyst forecast verified?
The data was verified on 2026-09-27. The dataset is valid through 2026-10-04.